» Articles » PMID: 37069813

Participation and Prognostic Impact of Cardiac Rehabilitation After Acute Coronary Syndrome: Big-Data Study of the Korean National Health Insurance Service

Overview
Specialty General Medicine
Date 2023 Apr 18
PMID 37069813
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To investigate the actual rate and quality of cardiac rehabilitation (CR) participation in South Korea and its short-term impact on clinical outcomes after acute coronary syndrome (ACS).

Methods: Data, including confirmed ACS diagnosis, socio-demographics, comorbidities, clinical outcomes, and CR claim codes, were collected from the Korean National Health Insurance Service claims database and compared between the CR and non-CR groups.

Results: Overall, 102,544 patients were included in the study, of which only 5.8% attended CR. Regarding testing, 83.6% of CR patients performed the cardiopulmonary exercise test, but follow-up testing was infrequently performed; in addition, 53.1% of them participated in an electrocardiogram monitoring exercise, but over half participated in only one session. After 1:1 propensity score matching, post-ACS cardiovascular events were significantly lower in the CR group than in the non-CR group. The cumulative 3-year hazard ratio for all-cause death was 0.612 (95% confidence interval [CI], 0.495-0.756), recurrent ACS was 0.92 (95% CI, 0.853-0.993), CR readmission was 0.817 (95% CI, 0.768-0.868), and major adverse cardiovascular events (MACE) was 0.827 (95% CI, 0.781-0.874) in the CR group. CR was associated with a significant dose-response effect on MACE, with a reduction in incidence from 0.854 to 0.711.

Conclusion: The actual rate of CR participation in South Korea remains low, and participation quality was not outstanding despite National Health Insurance coverage. Nevertheless, the impact of CR on cardiovascular outcomes after ACS was significantly superior. Efforts to increase CR participation should be increased by establishing new CR facilities and strategies to resolve associated barriers.

Citing Articles

Antiplatelet and Antithrombotic Activities of via Pharmacological Inhibition of Integrin IIb3, MAPK, and PI3K/AKT Pathways and FeCl3-Induced Murine Thrombosis.

Akram A, Saba E, Rhee M Evid Based Complement Alternat Med. 2024; 2024:9927160.

PMID: 38370873 PMC: 10872769. DOI: 10.1155/2024/9927160.


Still, Long Way to Go: Current Status and Perspective of Cardiac Rehabilitation in Korea.

Sung J J Korean Med Sci. 2023; 38(15):e122.

PMID: 37069815 PMC: 10111038. DOI: 10.3346/jkms.2023.38.e122.

References
1.
Seong S, Kim Y, Khang Y, Park J, Kang H, Lee H . Data Resource Profile: The National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2016; 46(3):799-800. PMC: 5837262. DOI: 10.1093/ije/dyw253. View

2.
Smith Jr S, Benjamin E, Bonow R, Braun L, Creager M, Franklin B . AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011; 124(22):2458-73. DOI: 10.1161/CIR.0b013e318235eb4d. View

3.
Hammill B, Curtis L, Schulman K, Whellan D . Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly Medicare beneficiaries. Circulation. 2009; 121(1):63-70. PMC: 2829871. DOI: 10.1161/CIRCULATIONAHA.109.876383. View

4.
Goto Y . Current state of cardiac rehabilitation in Japan. Prog Cardiovasc Dis. 2014; 56(5):557-62. DOI: 10.1016/j.pcad.2013.12.001. View

5.
Grace S, Shanmugasegaram S, Gravely-Witte S, Brual J, Suskin N, Stewart D . Barriers to cardiac rehabilitation: DOES AGE MAKE A DIFFERENCE?. J Cardiopulm Rehabil Prev. 2009; 29(3):183-7. PMC: 2928243. DOI: 10.1097/HCR.0b013e3181a3333c. View